George H. Talbot - Publications, H-index & Citations

George H. Talbot

Tufts Medical Center

52H指数

147论文数

1.4W被引数

收录论文 71

发表时间

Understanding Early and Late Endpoints in Registrational Trials of Community-acquired Bacterial Pneumonia

CLINICAL INFECTIOUS DISEASES

IF7.3

2020-06-25

OAAI

Talbot, George H.

Widening the Overton Window-While Avoiding Defenestration

CLINICAL INFECTIOUS DISEASES

IF7.3

2019-10-12

OAAI

Talbot, George H.

Clostridium difficile Infection-Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2019-05-03

OAAI

Talbot, George H.; Kleinman, Leah; Davies, Evan; Hunsche, Elke; Revicki, Dennis; Roberts, Laurie; Rosenberg, Daniel; Nord, Carl Erik

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

LANCET INFECTIOUS DISEASES

IF31

2019-03-01

OAAI

Gerding, Dale N.; Cornely, Oliver A.; Grill, Simon; Kracker, Hilke; Marrast, Anne Claire; Nord, Carl Erik; Talbot, George H.; Buitrago, Martha; Diaconescu, Iulian Gheorghe; de Oliveira, Claudia Murta; Preotescu, Liliana; Pullman, John; Louie, Thomas J.; Wilcox, Mark H.

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2019-02-21

144

OAAI

McKinnell, James A.; Dwyer, Jamie P.; Talbot, George H.; Connolly, Lynn E.; Friedland, Ian; Smith, Alex; Jubb, Adrian M.; Serio, Alisa W.; Krause, Kevin M.; Daikos, George L.

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

CLINICAL INFECTIOUS DISEASES

IF7.3

2019-02-04

116

OAAI

File, Thomas M., Jr.; Goldberg, Lisa; Das, Anita; Sweeney, Carolyn; Saviski, John; Gelone, Steven P.; Seltzer, Elyse; Paukner, Susanne; Wicha, Wolfgang W.; Talbot, George H.; Gasink, Leanne B.

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials 制定共识临床终点以评估未来医院获得性/呼吸机相关细菌性肺炎临床试验中的抗菌治疗效果

CLINICAL INFECTIOUS DISEASES

IF7.3

2019-02-04

OAAI

Weiss, Emmanuel; Zahar, Jean-Ralph; Alder, Jeff; Asehnoune, Karim; Bassetti, Matteo; Bonten, Marc J. M.; Chastre, Jean; De Waele, Jan; Dimopoulos, George; Eggimann, Philippe; Engelhardt, Marc; Ewig, Santiago; Kollef, Marin; Lipman, Jeffrey; Luna, Carlos; Martin-Loeches, Ignacio; Pagani, Leonardo; Palmer, Lucy B.; Papazian, Laurent; Poulakou, Garyphallia; Prokocimer, Philippe; Rello, Jordi; Rex, John H.; Shorr, Andrew F.; Talbot, George H.; Thamlikitkul, Visanu; Torres, Antoni; Wunderink, Richard G.; Timsit, Jean-Francois

The Infectious Diseases Society of America's 10 x ′20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 x ′20 a Possibility?

CLINICAL INFECTIOUS DISEASES

IF7.3

2019-02-01

120

OAAI

Talbot, George H.; Jezek, Amanda; Murray, Barbara E.; Jones, Ronald N.; Ebright, Richard H.; Nau, Gerard J.; Rodvold, Keith A.; Newland, Jason G.; Boucher, Helen W.

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2019-01-11

OAAI

Talbot, George H.; Das, Anita; Cush, Stephanie; Dane, Aaron; Wible, Michele; Echols, Roger; Torres, Antoni; Cammarata, Sue; Rex, John H.; Powers, John H.; Fleming, Thomas; Loutit, Jeffrey; Hoffmann, Steve; Alder, Jeff; Ariyasu, Mari; Boucher, Helen; Cammarata, Sue; Connolly, Lynn; Cush, Stephanie; Dane, Aaron; Das, Anita; De Anda, Carisa; Dixon, Dennis; Dudley, Mike; Echols, Roger; Ehlert, Janet; Eisenstein, Barry; Eisner, Mark; File, Thomas; Fleming, Thomas R.; Follmann, Dean; Friedland, H. David; Friedland, Ian; Hoffmann, Steve; Horga, Maria Arantxa; Howard, Kellee; Kartsonis, Nicholas A.; Kaufhold, Achim; Kindrick, Amy; Llorens, Lily; Loutit, Jeff; McGovern, Paul; Powers, John H.; Prokocimer, Philippe; Rex, John H.; Seltzer, Elyse; Sherman, Claire; Suffredini, Anthony; Torres, Antoni; Tsai, Larry; Wunderink, Richard

Evolution and current status of United States Food and Drug Administration and European Medicines Agency regulatory guidance for studies of nosocomial pneumonia 美国食品药品监督管理局和欧洲药品管理局对医院肺炎研究的监管指南的演变和现状

CURRENT OPINION IN CRITICAL CARE

IF3.4

2018-10-01

PREAI

Talbot, George H.

The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection

VALUE IN HEALTH

IF6

2018-04-01

OAAI

Kleinman, Leah; Talbot, George H.; Hunsche, Elke; Schuler, Rene; Nord, Carl Erik

Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance

CLINICAL INFECTIOUS DISEASES

IF7.3

2017-05-18

OAAI

Rex, John H.; Talbot, George H.; Goldberger, Mark J.; Eisenstein, Barry I.; Echols, Roger M.; Tomayko, John F.; Dudley, Michael N.; Dane, Aaron

The Fight Against Multidrug-Resistant Bacteria

ANNALS OF INTERNAL MEDICINE

IF15.2

2017-01-03

PREAI

Boucher, Helen W.; Cosgrove, Sara E.; Cox, Edward; Talbot, George H.

The Early Clinical Response Endpoint: Great Timing by the Food and Drug Administration?

CLINICAL INFECTIOUS DISEASES

IF7.3

2016-12-21

OAAI

Talbot, George H.

Patient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases

CLINICAL INFECTIOUS DISEASES

IF7.3

2016-07-31

OAAI

Powers, John H., III; Howard, Kellee; Saretsky, Todd; Clifford, Sarah; Hoffmann, Steve; Llorens, Lily; Talbot, George

In Vitro Activity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United States

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2016-07-01

OAAI

Mendes, Rodrigo E.; Farrell, David J.; Flamm, Robert K.; Talbot, George H.; Ivezic-Schoenfeld, Zrinka; Paukner, Susanne; Sader, Helio S.

Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies

DRUG SAFETY

IF3.8

2015-12-29

OAAI

Dunne, Michael W.; Talbot, George H.; Boucher, Helen W.; Wilcox, Mark; Puttagunta, Sailaja

Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health

CLINICAL INFECTIOUS DISEASES

IF7.3

2015-12-13

OAAI

Talbot, George H.; Powers, John H.; Hoffmann, Steven C.

Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-10-01

OAAI

Louie, Thomas; Nord, Carl Erik; Talbot, George H.; Wilcox, Mark; Gerding, Dale N.; Buitrago, Martha; Kracker, Hilke; Charef, Pascal; Cornely, Oliver A.

DEVELOPMENT OF A PATIENT-REPORTED OUTCOME INSTRUMENT (SKINFECT-PRO) TO STANDARDIZE AND QUALIFY SYMPTOMS OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSSI) FNIH BIOMARKERS CONSORTIUM CABP ABSI PROJECT TEAM '3

VALUE IN HEALTH

IF6

2015-05-01

OAAI

Powers, J. H.; Howard, K.; Saretsky, T.; Clifford, S.; Hoffmann, S. C.; Talbot, G. H.; Cimms, T. A.; Llorens, L.

研究方向